Melatonina Polfarmex (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This mimics the natural hormone released at night, signaling the body that it is time to sleep and helping to align the internal clock with the external light‑dark environment.

The appropriate dose of Melatonina Polfarmex is determined by a qualified prescriber based on the patient’s age, condition, and response to therapy. Dosage may vary, and the prescribing clinician will provide specific instructions.

Safety data for melatonin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melatonin differs from traditional hypnotics because it targets the body’s natural sleep‑regulating pathways rather than inducing sedation. It is generally considered to have a favorable safety profile, especially for short‑term use, whereas many prescription sleep aids may carry higher risks of dependence and next‑day impairment.

Store Melatonina Polfarmex at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and avoid storing it in areas with high humidity or temperature fluctuations.

Melatonina Polfarmex is taken orally, typically with a glass of water. It is usually taken shortly before the desired bedtime, following the dosing instructions provided by the prescribing clinician.

Serious but rare risks include severe allergic reactions such as rash, urticaria or anaphylaxis, and hormonal disturbances that could affect puberty in children. Any signs of severe hypersensitivity or unexpected mood changes should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin, those taking certain anticoagulants or immunosuppressants without medical supervision, and patients with uncontrolled psychiatric disorders should avoid using melatonin unless a healthcare professional determines it is appropriate.